
WuXi Biotech Firm Sells Facility Ahead of US Legislation Ban
Chinese biotech firm WuXi plans to sell its Ireland facility to Merck for $500 million as the BioSecure Act advances through the Senate and awaits presidential approval.
Views expressed in this video are opinions of the host and the guest(s), and do not necessarily reflect the views of NTD.